Paul Battaglia - Cellebrite Sr America

CLBT Stock  USD 19.93  0.06  0.30%   

Insider

Paul Battaglia is Sr America of Cellebrite DI
Address 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
Phone972 73 394 8000
Webhttps://www.cellebrite.com

Paul Battaglia Latest Insider Activity

Tracking and analyzing the buying and selling activities of Paul Battaglia against Cellebrite stock is an integral part of due diligence when investing in Cellebrite. Paul Battaglia insider activity provides valuable insight into whether Cellebrite is net buyers or sellers over its current business cycle. Note, Cellebrite insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cellebrite'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
 
Paul Battaglia over six months ago
Insider Trading

Cellebrite Management Efficiency

The company has return on total asset (ROA) of 0.0635 % which means that it generated a profit of $0.0635 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.885) %, meaning that it created substantial loss on money invested by shareholders. Cellebrite's management efficiency ratios could be used to measure how well Cellebrite manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.13 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.16). Total Current Liabilities is likely to drop to about 199.5 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 422.5 M in 2024
Cellebrite DI currently holds 14.13 M in liabilities. Cellebrite DI has a current ratio of 1.32, which is within standard range for the sector. Note, when we think about Cellebrite's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Vithya AubeeConsensus Cloud Solutions
35
Kelly BarrettEvertec
56
Marcel ErniGlobal Blue Group
56
Andrew StormSecureworks Corp
N/A
Eric MeuriceGlobal Blue Group
63
Shane DriggersEverCommerce
48
Scott TuricchiConsensus Cloud Solutions
60
Christopher AlaimoEverCommerce
56
Jeffrey SullivanConsensus Cloud Solutions
58
Greg GelhausGlobal Blue Group
48
Jorge CasalGlobal Blue Group
52
Patrick CostelloCSG Systems International
N/A
Michael AielloSecureworks Corp
N/A
John NebergallConsensus Cloud Solutions
64
Tomas MostanyGlobal Blue Group
52
Roxane DufourGlobal Blue Group
42
Eric RemerEverCommerce
52
Christian LucasGlobal Blue Group
52
Eric StrutzGlobal Blue Group
56
Sarah JordanEverCommerce
39
Elizabeth ClarkeSecureworks Corp
N/A
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people. Cellebrite DI (CLBT) is traded on NASDAQ Exchange in USA. It is located in 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602 and employs 1,008 people. Cellebrite is listed under Application Software category by Fama And French industry classification.

Management Performance

Cellebrite DI Leadership Team

Elected by the shareholders, the Cellebrite's board of directors comprises two types of representatives: Cellebrite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellebrite. The board's role is to monitor Cellebrite's management team and ensure that shareholders' interests are well served. Cellebrite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellebrite's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yossi Carmil, CEO Founder
Thomas Hogan, Executive Chairman
Zohar TadmorEilat, Chief Officer
Osnat Tirosh, Chief Officer
David Gee, Chief Officer
Adam Jaffe, VP Communications
Ayala Shapira, General Counsel
Marque Teegardin, President Management
Ronnen Armon, Chief Officer
Arnon Zilberman, Executive Operations
Andrew Kramer, Vice Relations
Dana Gerner, Chief Officer
Paul Battaglia, Sr America
Lisa Cole, Chief Officer
Leeor BenPeretz, Chief Officer
Anat EaronHeilborn, VP Relations
Marcus Jewell, Global Officer

Cellebrite Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellebrite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.